– Roots Rx is among the prime dispensary manufacturers inside Colorado, with prime quality cannabis, ease of ordering options, educated budtenders, and a novel loyalty program

– This transaction will add a further six dispensaries to the Firm’s retail footprint, bringing the whole variety of dispensaries to 23 upon closing of all pending acquisitions

– Roots Rx operates a big outside cultivation facility in Aspen that’s acknowledged for its high-quality merchandise and biomass

DENVER, Sept. 6, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or the "Company"), is pleased to announce its latest binding term sheet to acquire Roots Rx, a cannabis operator with six dispensaries located in the ski and mountain towns of Colorado. The Company will also acquire Roots Rx's outdoor cultivation facilities located outside of Aspen. This latest announcement comes on the heels of term sheets announced earlier this week to acquire a number of dispensaries, including retail locations using the Starbuds and Colorado Harvest Company brands and a series of independent dispensaries, which will bring the Company's total dispensary count to 23 upon the successful closing of all the pending acquisitions." data-reactid="14">DENVER, Sept. 6, 2019 /PRNewswire/ — Drugs Man Applied sciences, Inc. (MDCL) (“Drugs Man Applied sciences” or the “Firm”), is happy to announce its newest binding time period sheet to amass Roots Rx, a cannabis operator with six dispensaries positioned within the ski and mountain cities of Colorado. The Firm may also purchase Roots Rx’s outside cultivation amenities positioned outdoors of Aspen. This newest announcement comes on the heels of time period sheets introduced earlier this week to amass numerous dispensaries, together with retail areas utilizing the Starbuds and Colorado Harvest Firm manufacturers and a sequence of impartial dispensaries, which can deliver the Firm’s complete dispensary rely to 23 upon the profitable closing of all of the pending acquisitions.

Drugs Man Applied sciences Inc. Brand (PRNewsfoto/Drugs Man Applied sciences Inc.)

Underneath the phrases of the transaction, Drugs Man Applied sciences will buy Roots Rx   for a complete value of $15 million, which can include $7.5 million in money, the issuance of 1,779,661 shares of its frequent inventory at a value of $2.95 per share, and a deferred money cost of $2.25 million to be made a yr following the preliminary time limit. Based mostly on year-to-date outcomes, administration expects these six dispensaries to generate over $12 million in income in 2019 and in extra of $2.1 million in EBITDA. 

Andy Williams, Co-Founder and Chief Executive Officer of Medicine Man Technologies. "We are especially excited to gain retail presence beyond the Denver metro area and into the mountainous and resort regions of the state through the Roots Rx locations.  Medicine Man Technologies has built its foundation on aggregating a brain trust of the best and brightest pioneers of the industry. We are very pleased to welcome onto our team Robert Holmes and Steven Miller, two savvy and sophisticated operators, as well as their successful grow and retail stores. We feel that the combination of our businesses will result in operational synergies."" data-reactid="27">“We have been regionally targeted on plans to extend our retail capability and develop our presence, and this transfer is in line with our intention to vertically combine our develop, manufacturing, and state-wide retail amenities,” acknowledged Andy Williams, Co-Founder and Chief Govt Officer of Drugs Man Applied sciences. “We’re particularly excited to achieve retail presence past the Denver metro space and into the mountainous and resort areas of the state by the Roots Rx areas.  Drugs Man Applied sciences has constructed its basis on aggregating a mind belief of the most effective and brightest pioneers of the trade. We’re more than happy to welcome onto our group Robert Holmes and Steven Miller, two savvy and complex operators, in addition to their profitable develop and retail shops. We really feel that the mixture of our companies will end in operational synergies.”

“We began our household of dispensaries with the identical entrepreneurial spirit that Andy Williams and his group have used to construct Drugs Man Applied sciences into a number one regional cannabis operator,” commented Robert Holmes, Chief Govt Officer of Roots Rx. “Our shoppers will profit from the expanded product and model choices extra available to us underneath the Drugs Man Applied sciences umbrella following our transaction closings. To have the ability to be part of the record of trade pioneers that shall be concerned at Drugs Man Applied sciences is a improbable alternative for all of us at Roots Rx. We sit up for beginning this journey collectively.”

The six dispensaries that shall be acquired on this transaction are positioned in Aspen, Basalt, EagleVail, Edwards, Leadville, and Gunnison.

The phrases of the transaction will also be referenced within the Firm’s 8-Okay, which outlines the closing situations and are conditioned upon the satisfaction or mutual waiver of sure situations, together with regulatory approval.

For extra details about Drugs Man Applied sciences, please go to https://www.medicinemantechnologies.com.

Denver, Colorado-based Medicine Man Technologies (MDCL) is a rapidly growing provider of cannabis consulting services, nutrients and supplies.  The Company's client portfolio includes active and past clients in 20 states and 7 countries throughout the cannabis industry. The Company has entered into agreements to become one of the largest vertically integrated seed-to-sale operators in the global cannabis industry.  Currently contemplated transactions subject to term sheets, if closed, will enable Medicine Man Technologies to offer cultivation, extraction, distribution and retail pharma-grade products internationally.  The Company's intellectual property would include the "Three A Light" methodology for cannabis cultivation upon closing of pending acquisition candidate MedPharm's GMP-certified facility, which has the first cannabis research license to conduct clinical trials in the United States. Management includes decades of cannabis experience, a unique combination of first movers in industrial cannabis and proven Fortune 500 corporate executives." data-reactid="36">About Drugs Man Applied sciences
Denver, Colorado-based Drugs Man Applied sciences (MDCL) is a quickly rising supplier of cannabis consulting providers, vitamins and provides.  The Firm’s shopper portfolio consists of lively and previous purchasers in 20 states and seven international locations all through the cannabis trade. The Firm has entered into agreements to grow to be one of many largest vertically built-in seed-to-sale operators within the international cannabis trade.  At present contemplated transactions topic to time period sheets, if closed, will allow Drugs Man Applied sciences to supply cultivation, extraction, distribution and retail pharma-grade merchandise internationally.  The Firm’s mental property would come with the “Three A Mild” methodology for cannabis cultivation upon closing of pending acquisition candidate MedPharm’s GMP-certified facility, which has the primary cannabis analysis license to conduct scientific trials in america. Administration consists of a long time of cannabis expertise, a novel mixture of first movers in industrial cannabis and confirmed Fortune 500 company executives.

Ahead-Wanting Statements
This press launch comprises “forward-looking statements” inside the that means of the protected harbor provisions of the U.S. Non-public Securities Litigation Reform Act of 1995. Such statements could also be preceded by the phrases “intends,” “could,” “will,” “plans,” “expects,” “anticipates,” “initiatives,” “predicts,” “estimates,” “goals,” “believes,” “hopes,” “potential” or comparable phrases. Ahead-looking statements are neither historic details nor assurances of future efficiency. As an alternative, they’re primarily based solely on our present beliefs, expectations and assumptions concerning the way forward for our enterprise, future plans and methods, projections, anticipated occasions and traits, the economic system, and different future situations. As a result of forward-looking statements relate to the long run, they’re topic to inherent uncertainties, dangers and adjustments in circumstances which might be tough to foretell and plenty of of that are outdoors of our management. Such dangers and uncertainties embrace, with out limitation, dangers and uncertainties related to (i) regulatory limitations on our services and products; (ii) our skill to finish and combine acquisitions; (iii) common trade and financial situations; and (iv) our skill to entry satisfactory financing on phrases and situations which might be acceptable to us, in addition to different dangers recognized in our filings with the SEC. The Firm assumes no obligation to publicly replace or revise its forward-looking statements on account of new data, future occasions or in any other case.

Investor Relations Contact: 
[email protected]


View unique content material to obtain multimedia:http://www.prnewswire.com/news-releases/medicine-man-technologies-expands-its-retail-capabilities-with-the-planned-acquisition-of-roots-rx-a-highly-reputable-operator-with-six-dispensaries-and-cultivation-facilities-300913130.html